ask="3.70"
ask_size="100"
average_daily_volume="217140"
bid="N/A"
bid_size="N/A"
book_value="0.56"
change="+0.06"
change_from_200_day_moving_average="0.81"
change_from_50_day_moving_average="0.48"
change_from_52_week_high="-0.60"
change_From_52_week_low="1.21"
change_in_percent="+1.87%"
close="3.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="3.28"
high_52_weeks="3.87"
last_trade_date="2/10/2017"
last_trade_price="3.27"
last_trade_size="3824"
last_trade_time="4:00pm"
low="3.15"
low_52_weeks="2.06"
market_capitalization="61.11M"
moving_average_200_day="2.46"
moving_average_50_day="2.79"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="3.19"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+32.75%"
percent_change_from_50_day_moving_average="+17.31%"
percent_change_from_52_week_high="-15.50%"
percent_change_from_52_week_low="+58.74%"
previous_close="3.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.70"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.29"
stock_exchange="NCM"
symbol="BCLI"
volume="131649"
weeks_range_52="2.06 - 3.87"
